Jiangsu Hengrui Pharmaceuticals – World Class Benchmarking
Company: Jiangsu Hengrui Pharmaceuticals Company Limited
Bloomberg ticker: 600276 SH
Market cap: US$40,126m
Background: Jiangsu Hengrui Pharmaceuticals Company Limited develops, manufactures, and markets medicines and medicine packing materials. The Company produces anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
World Class Benchmarking of Jiangsu Hengrui Pharmaceuticals
- Profitable Growth rank of 2 was up compared to the prior period’s 3rd rank
- This is World Class performance compared to 360 large Health Care companies worldwide
- Profitability rank of 2 was better than its Growth rank of 3
- Profitability rank of 2 was the same compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
- Growth rank of 3 was up compared to the prior period’s 5th rank
- This is above average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.